HOME >> BIOLOGY >> NEWS
Discoverer of Sly Syndrome finds way of delivering medicine to fight rare genetic disorder

ST. LOUIS -- The scientist who discovered Sly Syndrome nearly four decades ago and a team of colleagues at Saint Louis University are a step closer to finding an approach to treat the rare genetic disease. Sly Syndrome causes bone defects, mental retardation, vision and hearing problems, heart disease and premature death.

They found that a potentially life-saving enzyme can be induced to cross the blood-brain barrier, a structure which protects the brain from foreign substances, if it is given with the hormone epinephrine.

Ever since William S. Sly, M.D., chairman of the department of biochemistry and molecular biology at Saint Louis University, discovered the rare genetic disease in 1969, he and his colleagues have conducted research to learn more about how to treat it. He says their recent findings have significance beyond treating the extremely rare disease that bears his name.

There are at most 100 living cases of Sly Syndrome. Nonetheless, this disease is a model for all the diseases in this group, some of which are much more common, Sly says.

Lysosomal storage diseases affect 1 in 7,000 live births, and 90 percent of those with the diseases have brain involvement. What we find with Sly Syndrome has some importance for all those diseases as well. It is potentially a big finding and an important first step.

The discovery potentially points to a new way to get big molecules, such as certain medications, across the blood-brain barrier. It is reported in the Proceedings of the National Academy of Sciences Online Early Edition the week of July 16.

SLU researchers found that the right amount of epinephrine probably works by stimulating transport by vesicles blister-like wrappers that carry substances across the blood-brain barrier so that the enzyme missing in patients who have Sly Syndrome can get into the brain.

Those who have Sly Syndrome lack the enzyme called beta-glucuronidase. Without
'"/>

Contact: Nancy Solomon
solomonn@slu.edu
314-977-8017
Saint Louis University
25-Jul-2007


Page: 1 2 3

Related biology news :

1. Researchers discover gene responsible for Restless Legs Syndrome
2. Study uncovers mutation responsible for Noonan Syndrome
3. New findings may lead to treatment for anxiety in Rett Syndrome
4. How Rett Syndrome mutation targets the brain
5. Brain derived neurotrophic factor alleviates disease symptoms in a mouse model of Rett Syndrome
6. Increasing norepinephrine stabilizes breathing patterns in a mouse model of Rett Syndrome
7. Univ. of Chicago scientists find potential cause of breathing problems in Rett Syndrome children
8. New data suggest pramipexole relieves symptoms of Restless Legs Syndrome (RLS) and is well-tolerated
9. Pramipexole delivered sustained efficacy in clinical trial of patients with Restless Legs Syndrome
10. Researchers at Yale identify a genetic link to Tourettes Syndrome
11. Discovery will aid identification of misregulated genes in Rett Syndrome

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2020)... ... February 13, 2020 , ... Pharmica Consulting announced ... operations executives and focusing on all facets of clinical trial planning and management. ... engagement, and more. , “We have attended the SCOPE Summit every year ...
(Date:2/11/2020)... ... February 11, 2020 , ... ... solving complex problems for life sciences companies and government agencies, announced the ... of management consulting expertise to Tunnell, with significant experience assessing, designing, and ...
(Date:2/7/2020)... ... 07, 2020 , ... dicentra , a leading clinical ... and dietary supplement industries, announces 2020 membership with the International Probiotics Association (“IPA”). ... pertaining to probiotics. We are thrilled to join our IPA member colleagues and ...
Breaking Biology News(10 mins):
(Date:1/28/2020)... ... January 28, 2020 , ... ... the exclusive distributor to food and beverage manufactures within North America. Both Lifecycle ... suppliers. This agreement will allow each company to pool their collective resources and ...
(Date:1/28/2020)... ... January 28, 2020 , ... Today, ... Kits . The new Salivary Total Human IgG Assay Kit exemplifies ... G in saliva, researchers can extend the accuracy and ease of use of ...
(Date:1/27/2020)... ... January 27, 2020 , ... Valencell, the leading ... strategic investors led by Halma plc , a FTSE 100 global group ... GII LLC, and WSJ Joshua Fund. A representative from Halma will join the ...
(Date:1/24/2020)... ... January 24, 2020 , ... The impact of ... diagnostics, therapeutics, laboratory and clinical services during the first two decades of the ... And as Slone Partners celebrates its 20th anniversary this year, its ...
Breaking Biology Technology:
Cached News: